These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16810405)

  • 1. Tardive dystonia, a case report.
    Veras AB; Rozenthal M; Nardi AE
    Braz J Psychiatry; 2006 Jun; 28(2):160-1. PubMed ID: 16810405
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe tongue protrusion dystonia: clinical syndromes and possible treatment.
    Schneider SA; Aggarwal A; Bhatt M; Dupont E; Tisch S; Limousin P; Lee P; Quinn N; Bhatia KP
    Neurology; 2006 Sep; 67(6):940-3. PubMed ID: 17000958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of intractable tardive lingual dyskinesia with botulinum toxin.
    Beckmann YY; Seçil Y; Saka S; Kuserli A; Çiftçi Y
    J Clin Psychopharmacol; 2011 Apr; 31(2):250-1. PubMed ID: 21364341
    [No Abstract]   [Full Text] [Related]  

  • 4. Tongue protrusion dystonia: treatment with botulinum toxin.
    Charles PD; Davis TL; Shannon KM; Hook MA; Warner JS
    South Med J; 1997 May; 90(5):522-5. PubMed ID: 9160072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact on quality of life of botulinum toxin treatments for spasmodic dysphonia and oromandibular dystonia.
    Bhattacharyya N; Tarsy D
    Arch Otolaryngol Head Neck Surg; 2001 Apr; 127(4):389-92. PubMed ID: 11296046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flupenthixol-induced tardive dystonia presenting as severe dysphagia.
    Agarwal PA; Ichaporia NR
    Neurol India; 2010; 58(5):784-5. PubMed ID: 21045513
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of tardive lingual dystonia with botulinum toxin: case report and review of the literature.
    Hennings JM; Krause E; Bötzel K; Wetter TC
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1167-71. PubMed ID: 17936461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy for segmental craniocervical dystonia (Meige syndrome) with aripiprazole, trihexyphenidyl, and botulinum toxin: three cases reports.
    Saito T; Katayama T; Sawada J; Kano K; Asanome A; Takahashi K; Sato N; Hasebe N
    Neurol Sci; 2015 Feb; 36(2):243-5. PubMed ID: 25151364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meige syndrome: what's in a name?
    LeDoux MS
    Parkinsonism Relat Disord; 2009 Aug; 15(7):483-9. PubMed ID: 19457699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tardive dystonia.
    van Harten PN; Kahn RS
    Schizophr Bull; 1999; 25(4):741-8. PubMed ID: 10667744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin as a treatment for tardive dyskinesia.
    van Harten PN; Hovestadt A
    Mov Disord; 2006 Aug; 21(8):1276-7. PubMed ID: 16671083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical therapy and botulinum toxin in dystonia.
    Jankovic J
    Adv Neurol; 1998; 78():169-83. PubMed ID: 9750914
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical profile of various sub-types of writer's cramp.
    Das CP; Prabhakar S; Truong D
    Parkinsonism Relat Disord; 2007 Oct; 13(7):421-4. PubMed ID: 17400019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate response to botulinum toxin injections in patients with fixed dystonia.
    Edwards MJ; Bhatia KP; Cordivari C
    Mov Disord; 2011 Apr; 26(5):917-8. PubMed ID: 21394784
    [No Abstract]   [Full Text] [Related]  

  • 15. Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study.
    Jankovic J; Orman J
    Neurology; 1987 Apr; 37(4):616-23. PubMed ID: 3561773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripherally induced oromandibular dystonia.
    Sankhla C; Lai EC; Jankovic J
    J Neurol Neurosurg Psychiatry; 1998 Nov; 65(5):722-8. PubMed ID: 9810945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of primary cranial dystonia (Meige's syndrome) with clozapine.
    Sieche A; Giedke H
    J Clin Psychiatry; 2000 Dec; 61(12):949. PubMed ID: 11206603
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical application of botulinum toxin type B in movement disorders and autonomic symptoms.
    Wan XH; Vuong KD; Jankovic J
    Chin Med Sci J; 2005 Mar; 20(1):44-7. PubMed ID: 15844312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tardive dyskinesia: clinical presentation and treatment.
    van Harten PN; Tenback DE
    Int Rev Neurobiol; 2011; 98():187-210. PubMed ID: 21907088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Indications for botulinum toxin in neurology].
    Ghika J; Küntzer T; Regli F
    Rev Med Suisse Romande; 1994 Jun; 114(6):551-5. PubMed ID: 8047771
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.